论文信息 - Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy - 字舞流文

Phase II study of buparlisib (BKM120) and trastuzumab in patients with HER2+ locally advanced or metastatic breast cancer resistant to trastuzumab-based therapy

S. Chan | A. Urruticoechea | T. Pluard | G. Jerusalem | B. Pistilli | T. Bachelot | A. Kong | C. Saura | C. Massacesi | P. Urban | E. Tomaso | H. Han | S. L. Mouhaër | D. Farci | S. L. Mouhaer | D. Robinson | T. Pluard | Stephen Chan | C. Saura | G. Jerusalem | Anthony Kong | Douglas Robinson